```html
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Anogenital Warts – 1-Page Ref Card</title>
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <style>
    :root {
      --primary: #006d77;
      --secondary: #83c5be;
      --accent: #e29578;
      --bg: #f7f9fb;
      --text: #212529;
      --light-text: #495057;
      --border: #dee2e6;
    }

    * {
      box-sizing: border-box;
    }
    body {
      margin: 0;
      font-family: "Segoe UI", Roboto, Helvetica, Arial, sans-serif;
      background: var(--bg);
      color: var(--text);
      line-height: 1.55;
    }

    .card {
      max-width: 800px;
      margin: 40px auto;
      background: #fff;
      border-radius: 16px;
      box-shadow: 0 8px 24px rgba(0,0,0,.08);
      overflow: hidden;
    }
    header {
      background: var(--primary);
      color: #fff;
      padding: 24px 32px;
    }
    header h1 {
      margin: 0;
      font-size: 1.75rem;
    }
    header p {
      margin: 4px 0 0;
      font-size: .95rem;
      opacity: .9;
    }

    section {
      padding: 24px 32px;
      border-bottom: 1px solid var(--border);
    }
    section:last-child {
      border-bottom: none;
    }
    h2 {
      margin: 0 0 12px;
      font-size: 1.3rem;
      color: var(--primary);
      display: flex;
      align-items: center;
      gap: 8px;
    }
    h2::before {
      content: '';
      display: inline-block;
      width: 20px;
      height: 4px;
      background: var(--accent);
      border-radius: 2px;
    }

    ul, ol {
      margin: 0;
      padding-left: 20px;
    }
    li {
      margin-bottom: 6px;
    }

    .btn-group {
      display: flex;
      gap: 12px;
      flex-wrap: wrap;
    }
    .btn {
      background: var(--secondary);
      color: var(--text);
      border: none;
      padding: 10px 18px;
      border-radius: 20px;
      font-size: .9rem;
      cursor: pointer;
      transition: .2s;
    }
    .btn:hover {
      background: var(--primary);
      color: #fff;
    }

    table {
      width: 100%;
      border-collapse: collapse;
      margin-top: 8px;
    }
    th, td {
      padding: 10px 12px;
      text-align: left;
      border-bottom: 1px solid var(--border);
    }
    th {
      background: var(--bg);
      font-weight: 600;
    }

    .alert {
      background: #fff3cd;
      border-left: 4px solid var(--accent);
      padding: 16px;
      margin-top: 12px;
      border-radius: 4px;
      font-size: .95rem;
    }

    .footer {
      font-size: .75rem;
      color: var(--light-text);
      text-align: center;
      padding: 16px;
    }

    @media (max-width: 600px) {
      header, section {
        padding-left: 20px;
        padding-right: 20px;
      }
      h1 {
        font-size: 1.5rem;
      }
    }
  </style>
</head>
<body>

  <div class="card">
    <header>
      <h1>Anogenital Warts – 1-Page Ref Card</h1>
      <p>Last updated May 2024 – BASHH 2024</p>
    </header>

    <section>
      <h2>Goal in 10 s</h2>
      <p>Benign HPV 6/11 lesions → remove warts, screen for STIs, counsel, refer if red-flags.</p>
    </section>

    <section>
      <h2>3-Step Algorithm</h2>
      <ol>
        <li><strong>Spot it – Clinical Dx:</strong> Cauliflower-like lesions anywhere anogenital; rule out mimics.</li>
        <li><strong>Triage – Refer or Treat:</strong>
          <ul>
            <li><strong>Refer</strong> if uncertain dx, intra-meatal/anal, pregnancy, immunosuppressed, child &lt;13 y.</li>
            <li><strong>Treat in primary care</strong> only if dx certain, patient declines referral, and you can screen STIs.</li>
          </ul>
        </li>
        <li>
          <strong>Treat – Choice Tree:</strong>
          <table>
            <thead>
              <tr><th>Lesion type</th><th>First-line</th></tr>
            </thead>
            <tbody>
              <tr><td>Soft / non-keratinised</td><td>Podophyllotoxin 0.5 % soln/cream</td></tr>
              <tr><td>Keratinised or mixed</td><td>Imiquimod 5 % cream OR cryotherapy</td></tr>
              <tr><td>Large / resistant</td><td>TCA 80-90 % OR excision</td></tr>
              <tr><td>Pregnancy</td><td>Cryotherapy / TCA (avoid topicals)</td></tr>
            </tbody>
          </table>
        </li>
      </ol>
    </section>

    <section>
      <h2>Dosing Cheat-Sheet</h2>
      <ul>
        <li><strong>Podophyllotoxin:</strong> 0.5 % soln/cream BID × 3 d, stop 4 d, repeat weekly × 4-5 (max area 4 cm²).</li>
        <li><strong>Imiquimod:</strong> 3×/wk at bedtime, wash off 6–10 h later, up to 16 wks.</li>
        <li><strong>Sinecatechins:</strong> 3×/day until clear ≤ 16 wks (max 250 mg/dose).</li>
      </ul>
    </section>

    <section>
      <h2>Red-Flags = Instant Referral</h2>
      <div class="alert">
        Bleeding / ulcerated lesions, haematuria, distorted urine stream, recurrent perianal warts, any child &lt;13 y (abuse screen).
      </div>
    </section>

    <section>
      <h2>30-Second Counsel</h2>
      <ul>
        <li>30 % clear spontaneously in 6 m.</li>
        <li>Treatments take 1–6 m; high failure/relapse rates.</li>
        <li>Use condoms, stop smoking to improve response.</li>
        <li>Partners may benefit from check-up.</li>
        <li>No change to cervical smear schedule.</li>
      </ul>
    </section>

    <section>
      <h2>Follow-Up</h2>
      <p>Review after each treatment course. &lt; 50 % response at 4–5 wks (8–12 wks for imiquimod) → change plan. Immunocompromised need closer watch.</p>
    </section>

    <div class="footer">
      © 2024 – Condensed from NICE CKS/BASHH 2024 guidance
    </div>
  </div>

</body>
</html>
```